Effects of prolonged versus acute indomethacin therapy in very low birth-weight infants with patent ductus arteriosus
- 1 June 1988
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Pediatrics
- Vol. 147 (5), 481-484
- https://doi.org/10.1007/bf00441971
Abstract
Indomethacin has proven effective in closing the patent ductus arteriosus (PDA) in most low birth weight (LBW) neonates with this disorder. Early reopening of the ductus is a problem and often leads to the need for surgery. Prolonged use of indomethacin for several days has been suggested as a means to alleviate this problem. The present study was designed to determine if prolonged therapy over 5 days is more effective than a two-dose regimen in preventing reopening of the PDA. Seventy neonates were randomized for either prolonged therapy over 1 week or to receive two doses of indomethacin. All infants were given two doses of indomethacin 0.15 mg per kg, 12 h apart. The maintenance group received an additional 0.1 mg per kg daily for 5 days. Ten days after the infants' initial dose of indomethacin, 6 of 22 in the nonmaintenance group as compared to 0 of 22 in the maintenance group had reopening of their ductus arteriosus. Ten infants in the maintenance group eventually had the ductus reopen at a median of 29, range 11–66 days compared to a median of 3, range 2–44 days in the nonmaintenance group. Significantly fewer babies in the maintenance group had a grade II–IV intraventricular hemorrhage compared to the nonmaintenance group. There was no other significant difference in the two groups in the incidence of necrotizing enterocolitis, retrolental fibroplasia or death. Indomethacin given over 5 days is effective for closure of the ductus arteriosus and will prevent reopening until after the acute clinical course in babies under 1500 g; however, the overall incidence of reopening was not different.Keywords
This publication has 21 references indexed in Scilit:
- Randomized indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight infantsThe Journal of Pediatrics, 1985
- Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in very-low-birth-weight infants with symptomatic patent ductus arteriosusThe Journal of Pediatrics, 1983
- Effects of indomethacin in premature infants with patent ductus arteriosus: Results of a national collaborative studyThe Journal of Pediatrics, 1983
- Beagle puppy model of intraventricular hemorrhageJournal of Neurosurgery, 1983
- Abnormal cerebral blood flow patterns in preterm infants with a large patent ductus arteriosusThe Journal of Pediatrics, 1982
- Prophylactic Indomethacin Therapy for Patent Ductus Arteriosus in Very-Low-Birth-Weight InfantsNew England Journal of Medicine, 1982
- Modulation of the pathophysiology of primate focal cerebral ischaemia by indomethacin.Stroke, 1982
- The effect of patent ductus arteriosus on flow velocity in the anterior cerebral arteries: Ductal steal in the premature newborn infantThe Journal of Pediatrics, 1981
- Prostaglandin I2 and indomethacin prevent impairment of post-ischemic brain reperfusion in the dog.Stroke, 1979
- Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gmThe Journal of Pediatrics, 1978